Lisa Coussens

Last updated
Lisa Coussens
Alma mater University of California, Los Angeles
San Francisco State University
Scientific career
Institutions Oregon Health & Science University
University of California, San Francisco
Genentech
Thesis Regulation of junB expression by transforming growth factor-beta, adenovirus12-E1A, and by the retinoblastoma susceptibility gene product  (1993)

Lisa M. Coussens is an American cancer scientist who is Professor and Chair of the Department of Cell, Developmental and Cancer Biology and Deputy Director for Basic and Translational Research in the Knight Cancer Institute at the Oregon Health & Science University. She served as 2022-2023 President of the American Association for Cancer Research.

Contents

Early life and education

Coussens was an undergraduate student at San Francisco State University. She worked at Genentech, Inc. (1981-1988) with Axel Ullrich PhD researching growth factor receptors and cloned the HER2 proto-oncogene. She moved to the University of California, Los Angeles for her doctoral research, where she studied JUNB expression. [1] She was a postdoctoral researcher working with Douglas Hanahan at the University of California, San Francisco where she used transgenic mouse models of multi-stage cancer progression and demonstrated that chronic inflammation is established in early cancers and subsequently drives tumor development. Her later research has identified critical immune-regulatory programs that represent cancer vulnerabilities that can be therapeutically targeted to slow cancer progression. [2]

Research and career

Coussens' research considers immune therapies for cancer treatment. [3] To do this, she looks at how immune cells regulate aspects of tumor cell development and the role of leukocytes. She makes use of breast, HPV-associated squamous, pancreas and mesothelioma mouse cancer models, in combination with human cancer specimens, to identify immune-regulated pathways that may be susceptible to therapeutic targeting. [4]

Coussens showed that some immune cells are hijacked to promote tumor growth and metastasis. She uncovered the intra-cellular communication processes which cause tumor cells to trigger CD4 T cells to recruit macrophages to early tumors. Macrophages are white blood cells that are usually involved with clearing debris, but produce epidermal growth factors when they are close to tumor cells, which promotes the proliferation and invasion of tumor cells. Her resesarch has emphasized the need to understand the tumor microenvironment in understanding cancer progression. She showed that dying cancer cells release factors that induce a CD8+ T cell-mediated immune response against cancer. [5]

In 2022, Coussens was elected President of the American Association for Cancer Research. [6] [7]

Awards and honors

Selected publications

Related Research Articles

The American Association for Cancer Research (AACR) is the world's oldest and largest professional association related to cancer research. Based in Philadelphia, the AACR focuses on all aspects of cancer research, including basic, clinical, and translational research into the etiology, prevention, diagnosis, and treatment of cancer. Founded in 1907 by 11 physicians and scientists, the organization now has more than 52,000 members in 130 countries and territories. The mission of the AACR is to prevent and cure cancer through research, education, communication, collaboration, science policy and advocacy, and funding for cancer research.

Axel Ullrich is a German cancer researcher and has been the director of the molecular biology department at the Max Planck Institute of Biochemistry in Martinsried, Germany since 1988. This department's research has primarily focused on signal transduction. Ullrich has received Hamdan Award for Medical Research Excellence, awarded by Sheikh Hamdan bin Rashid Al Maktoum Award for Medical Sciences, Dubai, United Arab Emirates in 2008 and Ullrich and his team received the Wolf Prize in 2010.

<span class="mw-page-title-main">Brian Druker</span> American physician-scientist

Brian J. Druker is a physician-scientist at Oregon Health & Science University (OHSU), in Portland, Oregon. He is the director of OHSU's Knight Cancer Institute, JELD-WEN Chair of Leukemia Research, Associate Dean for Oncology in the OHSU School of Medicine, and professor of medicine.

<span class="mw-page-title-main">Joan Massagué</span> Spanish biologist

Joan Massagué, is a Spanish biologist and the current director of the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center. He is also an internationally recognized leader in the study of both cancer metastasis and growth factors that regulate cell behavior, as well as a professor at the Weill Cornell Graduate School of Medical Sciences.

Alan D. D'Andrea is an American cancer researcher and the Fuller American Cancer Society Professor of Radiation Oncology at Harvard Medical School. D'Andrea's research at the Dana Farber Cancer Institute focuses on chromosome instability and cancer susceptibility. He is currently the director of the Center for DNA Damage and Repair and the director of the Susan F. Smith Center for Women's Cancer.

Zena Werb was a professor and the Vice Chair of Anatomy at the University of California, San Francisco. She was also the co-leader of the Cancer, Immunity, and Microenvironment Program at the Hellen Diller Family Comprehensive Cancer Center and a member of the Executive Committee of the Sabre-Sandler Asthma Basic Research Center at UCSF. Her research focused on features of the microenvironment surrounding cells, with particular interest in the extracellular matrix and the role of its protease enzymes in cell signaling.

Dafna Bar-Sagi is a cell biologist and cancer researcher at New York University School of Medicine. She is the Saul J. Farber Professor in the department of biochemistry and molecular pharmacology and the department of medicine and senior vice president and vice dean for science at NYU Langone Health. Bar-Sagi has been a member of scientific advisory boards, including the National Cancer Institute, Starr Cancer Consortium, and Pancreatic Cancer Action Network.

Guillermina 'Gigi' Lozano is an American geneticist. She is a professor at University of Texas MD Anderson Cancer Center. Lozano is recognised for her studies of the p53 tumour suppressor pathway, characterising the protein as a regulator of gene expression.

<span class="mw-page-title-main">Crystal Mackall</span> American physician and immunologist

Crystal L. Mackall is an American physician and immunologist. She is currently the Ernest and Amelia Gallo Family Professor of Pediatrics and Medicine at Stanford University. She is the founding director of the Stanford Center for Cancer Cell Therapy.

Pamela Sumiko Ohashi, PhD, FRSC is a Canadian medical researcher. She is co-director of the Campbell Family Institute for Breast Cancer Research, director of the Cancer Immune Therapy Program at the Princess Margaret Cancer Centre and a professor at the University of Toronto.

<span class="mw-page-title-main">Uğur Şahin</span> German oncologist and immunologist (born 1965)

Uğur Şahin is a German oncologist and immunologist. He is the founder and CEO of BioNTech, which developed one of the major vaccines against COVID-19. His main fields of research are cancer research and immunology.

Roy S. Herbst is an American oncologist who is the Ensign Professor of Medicine, Professor of Pharmacology, Chief of Medical Oncology, and Associate Director for Translational Research at Yale Cancer Center and Yale School of Medicine in New Haven, Connecticut.

Franziska Michor is an Austrian computational biologist. She is a professor in the department of data science at the Dana–Farber Cancer Institute. She serves as Director of the Physical Sciences-Oncology Center and the Center for Cancer Evolution.

<span class="mw-page-title-main">George Coukos</span> Tumor immunologist

George Coukos is a physician-scientist in tumor immunology, professor and director of the Ludwig Cancer Research Lausanne Branch and director of the Department of oncology UNIL-CHUV of the University of Lausanne and the Lausanne University Hospital in Lausanne, Switzerland. He is known for his work on the mechanisms by which tumors suppress anti-cancer immune responses, and the role of the tumor vasculature in that suppression. In addition to his work in ovarian cancer, the combinatorial immune therapies proposed by Professor Coukos have been successfully tested and approved for lung, liver and kidney cancers.

Philip Greenberg is a professor of medicine, oncology, and immunology at the University of Washington and head of program in immunology at the Fred Hutchinson Cancer Research Center. His research is centered around T cell biology and therapeutic cell therapies. He is a co-founder of Juno Therapeutics.

Cornelis Joseph Maria Melief is a globally recognised immunology expert specialising in cancer immunology and immunotherapy, with special focus on therapeutic cancer vaccines. He is Emeritus Professor, former head of the Department of Immunohematology and Blood Transfusion at the Leiden University Medical Center, and Chief Scientific Officer at ISA Therapeutics in Netherlands. He is known for his work in the field of cancer immunology, devising new cancer therapies based on the activation of the patient’s own immune system.

<span class="mw-page-title-main">María Soengas</span> Spanish immunologist and academic

María S. (Marisol) Soengas is a Spanish immunologist who is a senior scientist at the Spanish National Cancer Research Center (CNIO). Her research considers melanoma and the development of new therapeutic strategies. She was elected to the European Molecular Biology Organization in 2022.

Karina Elizabeth de Visser, also named "Karin E. de Visser", is a researcher at the Netherlands Cancer Institute. Her research considers metastatic formation and how the immune system influences how people respond to cancer treatment.

<span class="mw-page-title-main">Edna Cukierman</span> Mexican biochemist and academic

Edna "Eti" Cukierman is a Mexican biochemist who is a professor at the Fox Chase Cancer Center. She serves as co-director of the Marvin & Concetta Greenberg Pancreatic Cancer Institute. Her research investigates pancreatic cancer and the tumor microenvironment.

<span class="mw-page-title-main">Christina Curtis</span> American physician and academic

Christina Curtis is an American scientist who is a Professor of Medicine, Genetics and Biomedical Data Science and an Endowed Scholar at Stanford University where her research investigates the evolution of tumors. She is director of Artificial Intelligence and Cancer Genomics at Stanford University School of Medicine and is on the board of directors of the American Association for Cancer Research.

References

  1. ↑ Coussens, Lisa Marie (1993). Regulation of junB expression by transforming growth factor-beta, adenovirus12-E1A, and by the retinoblastoma susceptibility gene product. OCLC   732921603.
  2. ↑ "Lisa M. Coussens M.D. (h.c.), Ph.D., FAACR | OHSU People | OHSU". www.ohsu.edu. Retrieved 2022-07-26.
  3. ↑ "Lisa Coussens". NFCR. Retrieved 2022-07-26.
  4. ↑ Inc, Kineta. "Kineta Announces Formation of New Immuno-oncology Focused Scientific Advisory Board". www.prnewswire.com (Press release). Retrieved 2022-07-26.{{cite press release}}: |last= has generic name (help)
  5. 1 2 "Breast Cancer Awards & Recognition". Susan G. Komen. Retrieved 2022-07-26.
  6. 1 2 Burns, Matthew. "American Association for Cancer Research Inaugurates New Leadership at the AACR Annual Business Meeting of Members 2022". American Association for Cancer Research (AACR). Retrieved 2022-07-26.
  7. ↑ "Q&A: Lisa Coussens on Her Leadership Year Ahead". Cancer Discovery. 12 (5): OF3. 2022-05-02. doi:10.1158/2159-8290.CD-ND2022-0003. ISSN   2159-8274. PMID   35344030. S2CID   247763495.
  8. ↑ McLaughlin, Erin. "AACR Gertrude B. Elion Cancer Research Award". American Association for Cancer Research (AACR). Retrieved 2022-07-26.
  9. ↑ Beveridge, Michael. "AACR-Women in Cancer Research Charlotte Friend Lectureship: Past Recipients". American Association for Cancer Research (AACR). Retrieved 2022-07-26.
  10. ↑ "Past Winners of the NCI Rosalind E. Franklin Award - NCI". dceg.cancer.gov. 2017-02-06. Retrieved 2022-07-26.
  11. ↑ Beveridge, Michael. "AACR Princess Takamatsu Memorial Lectureship: Past Recipients". American Association for Cancer Research (AACR). Retrieved 2022-07-26.
  12. ↑ "OHSU scientists Lisa Coussens, John Crabbe named 2018 AAAS fellows | OHSU Research News". OHSU Research News | Research News at OHSU. 2018-12-03. Retrieved 2022-07-26.
  13. ↑ https://bg.linkedin.com/posts/society-for-immunotherapy-of-cancer-sitc_we-are-delighted-to-welcome-dr-lisa-m-coussens-activity-6990311019914874880-FCaT
  14. ↑ https://www.nasonline.org/news-and-multimedia/news/2023-nas-election.html
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.